FDA head discusses challenges, criticisms

03/4/2007 | Houston Chronicle (tiered subscription model)

FDA commissioner Dr. Andrew von Eschenbach has faced numerous criticisms ranging from political and pharmaceutical industry influence at the agency to accusations of containing dissent and threatening whistle-blowers. In an interview, he acknowledged the challenges facing the FDA and said the group is "a team few people fully appreciate."

View Full Article in:

Houston Chronicle (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care